January 29, 2021
Efficacy and Safety of Sorafenib Plus Vitamin K Treatment for Hepatocellular CarcinomA: A Phase II, Randomized Study BookmarkGeorge Lundberg, MD
This scientific research paper published in the journal Cancer Medicine reports that the drug sorafenib has shown some effectiveness against hepatocellular carcinoma in a clinical trial, and that adding vitamin K2 enhanced that effectiveness.
November 24, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib BookmarkGeorge Lundberg, MD
This scientific research paper published in JAMA Oncology reports results from a clinical trial in which the drugs nivolumab and ipilimumab showed promising safety and efficacy for people with advanced liver cancer who had previously received the drug sorafenib.
October 8, 2020
Innovent Biologics’s TYVYT/Byvasda combo shows survival benefit in late-stage liver cancer study BookmarkGeorge Lundberg, MD
Article from Seeking Alpha curated by Contributing Editor George Lundberg, MD, who notes:
In a phase 3 clinical trial, a new drug combination improved both overall survival and progression-free survival for people with hepatocellular carcinoma.